These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27068334)

  • 1. Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance.
    Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):769-81. PubMed ID: 27068334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study.
    Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
    Amino Acids; 2016 Feb; 48(2):535-47. PubMed ID: 26439377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frog skin host-defense peptide CPF-SE1 improves glucose tolerance, insulin sensitivity and islet function and decreases plasma lipids in high-fat fed mice.
    Srinivasan D; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YHA
    Eur J Pharmacol; 2015 Oct; 764():38-47. PubMed ID: 26123844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of the antidiabetic peptide [S4K]CPF-AM1 in db/db mice.
    Musale V; Moffett RC; Owolabi B; Conlon JM; Flatt PR; Abdel-Wahab YHA
    J Mol Endocrinol; 2021 Feb; 66(2):115-128. PubMed ID: 33252358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study.
    Musale V; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YH
    Peptides; 2021 Feb; 136():170472. PubMed ID: 33338546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance.
    Ojo OO; Srinivasan DK; Owolabi BO; Vasu S; Conlon JM; Flatt PR; Abdel-Wahab YH
    PLoS One; 2015; 10(10):e0141549. PubMed ID: 26512980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-diabetic actions of esculentin-2CHa(1-30) and its stable analogues in a diet-induced model of obesity-diabetes.
    Vasu S; Ojo OO; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YHA
    Amino Acids; 2017 Oct; 49(10):1705-1717. PubMed ID: 28836148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
    Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
    Eur J Pharmacol; 2020 Jul; 878():173101. PubMed ID: 32320703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice.
    Graham GV; McCloskey A; Abdel-Wahab YH; Conlon JM; Flatt PR
    Mol Cell Endocrinol; 2020 Jan; 499():110584. PubMed ID: 31539596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting RHOA Signaling in Mice Increases Glucose Tolerance and Numbers of Enteroendocrine and Other Secretory Cells in the Intestine.
    Petersen N; Frimurer TM; Terndrup Pedersen M; Egerod KL; Wewer Albrechtsen NJ; Holst JJ; Grapin-Botton A; Jensen KB; Schwartz TW
    Gastroenterology; 2018 Oct; 155(4):1164-1176.e2. PubMed ID: 29935151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms mediating the beneficial metabolic effects of [Arg4]tigerinin-1R in mice with diet-induced obesity and insulin resistance.
    Ojo OO; Srinivasan DK; Owolabi BO; McGahon MK; Moffett RC; Curtis TM; Conlon JM; Flatt PR; Abdel-Wahab YH
    Biol Chem; 2016 Aug; 397(8):753-64. PubMed ID: 26966929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice.
    Srinivasan DK; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YH
    Acta Diabetol; 2016 Apr; 53(2):303-15. PubMed ID: 26138324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
    McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity.
    Joannides CN; Mangiafico SP; Waters MF; Lamont BJ; Andrikopoulos S
    Diabetes Obes Metab; 2017 Aug; 19(8):1135-1146. PubMed ID: 28244693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential.
    Pathak NM; Pathak V; Gault VA; McClean S; Irwin N; Flatt PR
    Biochem Pharmacol; 2018 Sep; 155():264-274. PubMed ID: 30028989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
    Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
    Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice.
    Brandt C; Hansen RH; Hansen JB; Olsen CH; Galle P; Mandrup-Poulsen T; Gehl J; Pedersen BK; Hojman P
    Metabolism; 2015 Feb; 64(2):283-95. PubMed ID: 25456456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.